PROC and Sepsis: Another anticoagulant, recombinant human activated protein C (rhAPC), was reported to decrease mortality in the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study [7], and post hoc data analysis demonstrated that patients with DIC may have a survival benefit in particular [8].